Infiltration of Th1 and Th17 cells and activation of microglia in the CNS during the course of experimental autoimmune encephalomyelitis
- PMID: 20138983
- DOI: 10.1016/j.bbi.2010.01.014
Infiltration of Th1 and Th17 cells and activation of microglia in the CNS during the course of experimental autoimmune encephalomyelitis
Abstract
Experimental autoimmune encephalomyelitis (EAE) is a mouse model for multiple sclerosis, where disease is mediated by autoantigen-specific T cells. Although there is evidence linking CD4(+) T cells that secrete IL-17, termed Th17 cells, and IFN-gamma-secreting Th1 cells with the pathogenesis of EAE, the precise contribution of these T cell subtypes or their associated cytokines is still unclear. We have investigated the infiltration of CD4(+) T cells that secrete IFN-gamma, IL-17 or both cytokines into CNS during development of EAE and have examined the role of T cells in microglial activation. Our findings demonstrate that Th17 cells and CD4(+) T cells that produce both IFN-gamma and IL-17, which we have called Th1/Th17 cells, infiltrate the brain prior to the development of clinical symptoms of EAE and that this coincides with activation of CD11b(+) microglia and local production of IL-1beta, TNF-alpha and IL-6 in the CNS. In contrast, significant infiltration of Th1 cells was only detected after the development of clinical disease. Co-culture experiments, using mixed glia and MOG-specific T cells, revealed that T cells that secreted IFN-gamma and IL-17 were potent activators of pro-inflammatory cytokines but T cells that secrete IFN-gamma, but not IL-17, were less effective. In contrast both Th1 and Th1/Th17 cells enhanced MHC-class II and co-stimulatory molecule expression on microglia. Our findings suggest that T cells which secrete IL-17 or IL-17 and IFN-gamma infiltrate the CNS prior to the onset of clinical symptoms of EAE, where they may mediate CNS inflammation, in part, through microglial activation.
Copyright 2010 Elsevier Inc. All rights reserved.
Similar articles
-
TNF-alpha expression by resident microglia and infiltrating leukocytes in the central nervous system of mice with experimental allergic encephalomyelitis. Regulation by Th1 cytokines.J Immunol. 1995 Jan 15;154(2):944-53. J Immunol. 1995. PMID: 7814894
-
Activation of mixed glia by Abeta-specific Th1 and Th17 cells and its regulation by Th2 cells.Brain Behav Immun. 2010 May;24(4):598-607. doi: 10.1016/j.bbi.2010.01.003. Epub 2010 Jan 12. Brain Behav Immun. 2010. PMID: 20060887
-
The central nervous system environment controls effector CD4+ T cell cytokine profile in experimental allergic encephalomyelitis.Eur J Immunol. 1997 Nov;27(11):2840-7. doi: 10.1002/eji.1830271115. Eur J Immunol. 1997. PMID: 9394808
-
Evidence that Fas and FasL contribute to the pathogenesis of experimental autoimmune encephalomyelitis.Arch Immunol Ther Exp (Warsz). 2000;48(5):381-8. Arch Immunol Ther Exp (Warsz). 2000. PMID: 11140465 Review.
-
Role of Th17 cells in the pathogenesis of CNS inflammatory demyelination.J Neurol Sci. 2013 Oct 15;333(1-2):76-87. doi: 10.1016/j.jns.2013.03.002. Epub 2013 Apr 8. J Neurol Sci. 2013. PMID: 23578791 Free PMC article. Review.
Cited by
-
Prophylactic effects of cucurbitacin B in the EAE Model of multiple sclerosis by adjustment of STAT3/IL-23/IL-17 axis and improvement of neuropsychological symptoms.Metab Brain Dis. 2022 Dec;37(8):2937-2953. doi: 10.1007/s11011-022-01083-5. Epub 2022 Oct 26. Metab Brain Dis. 2022. PMID: 36287356
-
Interleukin-6, a major cytokine in the central nervous system.Int J Biol Sci. 2012;8(9):1254-66. doi: 10.7150/ijbs.4679. Epub 2012 Oct 25. Int J Biol Sci. 2012. PMID: 23136554 Free PMC article. Review.
-
Mechanisms of M2 Macrophage-Derived Exosomal Long Non-coding RNA PVT1 in Regulating Th17 Cell Response in Experimental Autoimmune Encephalomyelitisa.Front Immunol. 2020 Sep 4;11:1934. doi: 10.3389/fimmu.2020.01934. eCollection 2020. Front Immunol. 2020. Retraction in: Front Immunol. 2021 Sep 24;12:773900. doi: 10.3389/fimmu.2021.773900. PMID: 33013847 Free PMC article. Retracted.
-
Current status of the immunomodulation and immunomediated therapeutic strategies for multiple sclerosis.Clin Dev Immunol. 2012;2012:970789. doi: 10.1155/2012/970789. Epub 2011 Dec 6. Clin Dev Immunol. 2012. PMID: 22203863 Free PMC article. Review.
-
Tolerogenic Vaccination with MOG/VitD Overcomes Aggravating Effect of C. albicans in Experimental Encephalomyelitis.CNS Neurosci Ther. 2016 Oct;22(10):807-16. doi: 10.1111/cns.12572. Epub 2016 Jun 19. CNS Neurosci Ther. 2016. PMID: 27321391 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials